Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
168.37
+0.28 (0.17%)
At close: Jul 14, 2025, 4:00 PM
167.25
-1.12 (-0.67%)
After-hours: Jul 14, 2025, 7:45 PM EDT
Quest Diagnostics Market Cap
Quest Diagnostics has a market cap or net worth of $18.80 billion as of July 14, 2025. Its market cap has increased by 22.34% in one year.
Market Cap
18.80B
Enterprise Value
25.18B
1-Year Change
22.34%
Ranking
Category
Stock Price
$168.37
Market Cap Chart
Since December 1, 1998, Quest Diagnostics's market cap has increased from $531.80M to $18.80B, an increase of 3,434.42%. That is a compound annual growth rate of 14.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 18.76B | 11.44% |
| Dec 31, 2024 | 16.84B | 8.62% |
| Dec 29, 2023 | 15.50B | -12.99% |
| Dec 30, 2022 | 17.82B | -16.05% |
| Dec 31, 2021 | 21.22B | 32.15% |
| Dec 31, 2020 | 16.06B | 11.65% |
| Dec 31, 2019 | 14.38B | 26.95% |
| Dec 31, 2018 | 11.33B | -15.59% |
| Dec 29, 2017 | 13.42B | 5.36% |
| Dec 30, 2016 | 12.74B | 24.94% |
| Dec 31, 2015 | 10.20B | 5.21% |
| Dec 31, 2014 | 9.69B | 24.48% |
| Dec 31, 2013 | 7.79B | -15.94% |
| Dec 31, 2012 | 9.26B | 1.13% |
| Dec 30, 2011 | 9.16B | -0.41% |
| Dec 31, 2010 | 9.20B | -17.62% |
| Dec 31, 2009 | 11.16B | 9.95% |
| Dec 31, 2008 | 10.15B | -0.86% |
| Dec 31, 2007 | 10.24B | -0.93% |
| Dec 29, 2006 | 10.34B | -0.63% |
| Dec 30, 2005 | 10.40B | 7.59% |
| Dec 31, 2004 | 9.67B | 27.23% |
| Dec 31, 2003 | 7.60B | 36.58% |
| Dec 31, 2002 | 5.56B | -18.81% |
| Dec 31, 2001 | 6.85B | 4.46% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.60B |
| Johnson & Johnson | 377.32B |
| AbbVie | 338.30B |
| Novo Nordisk | 308.09B |
| UnitedHealth Group | 272.67B |
| Novartis AG | 237.08B |
| Abbott Laboratories | 229.71B |
| AstraZeneca | 222.35B |